Evidence for RANTES, monocyte chemotactic protein-1, and macrophage inflammatory protein-1β expression in Kawasaki disease

Journal of Rheumatology

Volumn 24, Issue 6, 1997, Pages 1179-1185

  Wong, Mark ^a   Silverman, Earl D ^b   Fish, Eleanor N ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Chemokine; Kawasaki disease

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN G; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL;

CHEMOKINE CCL2; CHEMOKINES; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; MACROPHAGE INFLAMMATORY PROTEIN-1; MUCOCUTANEOUS LYMPH NODE SYNDROME; POLYMERASE CHAIN REACTION; RANTES; RNA, MESSENGER;

EID: 0030988264     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Kawasaki T: Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children: Clinical observations of 50 cases. Jpn J Allergol 1967;16:178-222.
2. Burns JC, Mason WH, Glode MP, et al: Clinical and epidemiological characteristics of patients referred for evaluation of possible Kawasaki disease. J Pediatr 1991;118:680-6.
3. Melish ME, Hicks RV: Kawasaki syndrome: Clinical features, pathophysiology, etiology and therapy. J Rheumatol 1990;17:2-10.
4. Leung DYM: Immunologic aspects of Kawasaki disease: Implications for pathogenesis and therapy. Clin Cardiol 1991; (suppl 2)14:11-5.
5. Lin CY, Hwang BW: Serial immunologic studies in patients with mucocutaneous lymph node syndrome (Kawasaki disease). Ann Allergy 1987;59:291-7.
6. Barron KS, DeCunto C, Montalvo J, Orson F, Lewis D: Abnormalities of immunoregulation in Kawasaki syndrome. J Rheumatol 1988;15:1243-9.
7. Abe J, Kotzin BL, Jujo K, et al: Selective expansion of T cells expressing T-cell receptor variable regions Vβ2 and Vβ8 in Kawasaki disease. Proc Natl Acad Sci 1992;89:4066-70.
8. Leung DYM, Siegel RL, Grady S, et al: Immunoregulatory abnormalities in mucocutaneous lymph node syndrome. Clin Immunol Immunopathol 1982;23:100-12.
9. Terai M, Kohno Y, Niwa K, Toba T, Sakural N, Nakajima H: Imbalance among T-cell subsets in patients with coronary arterial aneurysms in Kawasaki disease. Am J Cardiol 1987;60:555-9.
10. Furukawa S, Matsubara T, Tsuji K, Motohashi T, Okumura K, Yabuta K: Serum soluble CD4 and CD8 levels in Kawasaki disease. Clin Exp Immunol 1991;86:134-9.
11. Furukawa S, Matsubara T, Obara T, Okumura K, Yabuta K: Soluble CD2 levels in serum during acute Kawasaki disease and infectious mononucleosis. J Infect Dis 1993;167:778-9.
12. Pietra BA, De Inocencio J, Giannini EH, Hirsch R: TCR Vβ family repertoire and T cell activation markers in Kawasaki disease. J Immunol 1994;153:1881-8.
13. Maury CPJ, Salo E, Pelkonen P: Circulating interleukin-1 in patients with Kawasaki disease. N Engl J Med 1988;319:1670-1.
14. Leung DYM, Cotran RS, Kurt-Jones E, Burns JC, Newburger JW, Pober JS: Endothelial cell activation and increased interleukin-1 secretion in the pathogenesis of acute Kawasaki disease. Lancet 1989;2:1298-302.
15. Lin CY, Lin CC, Hwang B, Chiang BN: The changes of interleukin-2, tumor necrosis factor and gamma interferon production among patients with Kawasaki disease. Eur J Pediatr 1997;150:179-82.
16. Furukawa S, Matsubara T, Jujoh K, et al: Peripheral blood monocyte/macrophage and serum tumor necrosis factor in Kawasaki disease. Clin Immunol Immunopathal 1988;48:274-51.
17. Lang BA, Silverman ED, Laxer RM, Lau AS: Spontaneous tumor necrosis factor production in Kawasaki disease. J Pediatr 1989;115:939-43.
18. Matsubara T, Furukawa S, Yabuta K: Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease. Clin Immunol Immunopathol 1990;56:29-36.
19. Lin CY, Lin CC, Hwang B, Chiang BN: Cytokines predict coronary aneurysm formation in Kawasaki disease patients. Eur J Pediatr 1993;152:309-12.
20. Rowley AH, Shulman ST, Preble OT, Poiesz BJ, Ehrlich GD, Sullivan JR: Serum interferon concentrations and retroviral serology in Kawasaki syndrome. Pediatr Infect Dis J 1988;7:663-6.
21. Ueno Y, Takano N, Kanegane H, et al: The acute phase nature of interleukin 6: Studies in Kawasaki disease and other febrile illness. Clin Exp Immunol 1989;76:337-42.
22. Lang BA, Silverman ED, Laxer RM, Rose V, Nelson DL, Rubin LA: Serum soluble interleukin-2 receptor levels in Kawasaki disease. J Pediatr 1990;116:592-6.
23. Eberhard BA, Andersson U, Laxer RM, Rose V, Silverman ED: Evaluation of the cytokine response in Kawasaki disease. Pediatr Infect Dis J 1995;14:199-203.
24. Schall TJ: The chemokines. In: The Cytokine Handbook., 2nd ed. New York: Academic Press, 1994:419-60.
25. Zachariae CO, Anderson AO, Thompson HL, et al: Properties of monocyte chemotactic and activating factor (MCAF) purified from a human fibrosarcoma cell line. J Exp Med 1990;171:2177-82.
26. Rollins BJ, Walz A, Baggiolini M: Recombinant human MCP-1/JE induces chemotaxis, calcium flux, and the respiratory burst in human monocytes. Blood 1991;78:1112-6.
27. Jiang Y, Beller DI, Frendl G, Graves DT: Monocyte chemoattractant protein-1 regulated adhesion molecule expression and cytokine production in human monocytes. J Immunol 1992;148:2434-28.
28. Schall TJ: Biology of the RANTES/SIS cytokine family. Cytokine 1991;3:165-83.
29. Taub DD, Conlon K, Lloyd AR, Oppenheim JJ, Kelvin DJ: Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1 alpha and MIP-1 beta. Science 1993;260:355-8.
30. Schall TJ, Bacon K, Camp RD, Kaspari JW, Goeddel DV: Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes. J Exp Med 1993;177:1821-6.
31. Chomczynski P, Sacchi N: Single step method of RNA isolation by guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
32. Roth MJ, Tanese N, Goff SP: Purification and characterization of murine retroviral reverse transcriptase expressed in E. coli. J Biol Chem 1985;260:9326-35.
33. Li YS, Shyy YJ, Wright JG, Valente AJ, Cornhill JF, Kolattukudy PE: The expression of monocyte chemotactic protein (MCP-1) in human vascular endothelium in vitro and in vivo. Mol Cell Biochem 1993;126:61-8.
34. Shyy YJ, Wickham LL, Hagan JP, et al: Human monocyte colony-stimulating factor stimulates the gene expression of monocyte chemotactic protein-1 and increases the adhesion of monocytes to endothelial monolayers. J Clin Invest 1993;92:1745-51.
35. Koch AE, Kunkel SL, Pearce WH, et al: Detection of the chemotactic cytokines interleukin-8 and monocyte chemotactic protein-1 in human abdominal aortic aneurysms. Am J Pathol 1993;142:1423-31.
36. Takeya M, Yoshimura T, Leonard EJ, Takahashi K: Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody. Hum Pathol 1993;24:534-9.
37. Gordon D, Wilcox JN: Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 1991;88:1121-7.
38. Wick G, Schett G, Amberger A, Kleindienst R, Xu Q: Is atherosclerosis an immunologically mediated disease? Immunol Today 1995;16:27-33.
39. Schmouder RL, Strieter RM, Kunkel SL: Interferon-γ regulation of human renal cortical epithelial cell-derived monocyte chemotactic peptide-1. Kidney Int 1993;44:43-9.
40. Brown Z, Gerritsen ME, Carley WW, Strieter RM, Kunkel SL, Westwick J: Chemokine gene expression and secretion by cytokine-activated human microvacular endothelial cells. Am J Pathol 1994;145:913-21.
41. Jiang Y, Beller DI, Frendl G, Graves DT: Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. J Immunol 1992;148:2423-8.
42. Tanaka Y, Adams DH, Hubscher S, Hirano H, Siebenlist U, Shaw S: T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta. Nature 1993;361:79-82.
43. Furukawa S, Matsubara T, Motohashi T, Tsuda M, Sugimoto H, Yabuta K: Immunological abnormalities in Kawasaki disease with coronary artery lesions. Acta Paediatr Jpn 1991;33:745-51.
44. Leung DY, Geha RS, Newburger JW, et al: Two monokines, interleukin-1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome. J Exp Med 1986;164:1958-72.